Antioxidant Claim Concerns In FDA Warning To Personal Care Ingredient Firm
This article was originally published in The Tan Sheet
Executive Summary
FDA’s letter to Essential Wholesale – one of two drug claim warnings issued to cosmetics firms in November – highlights claims for non-monograph ingredients that render the firm’s offerings drugs, according to the agency. The letter followed an inspection of the company’s facility in April 2014 and a review of its website.